Trump’s Tariff Tactics: Investors Discover the “TACO” Strategy
In essence, the seemingly contradictory stance of NIH head Jay Bhattacharya, a proponent of academic freedom, is complicated by his involvement in a new journal, the Journal of the Academy of Public Health, alongside FDA chief Marty Makary. This journal, while aesthetically well-designed, has raised concerns due to its publication of primarily contrarian viewpoints on COVID-19, lacking representation of widely accepted epidemiological consensus. Both Bhattacharya and Makary are listed as on leave from the journal, adding to the controversy. Critics argue this undermines the claimed support for academic freedom, suggesting a potential conflict of interest and a platform for misinformation.
John Q. Hosedrinker